Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, do... by Madhi, SA, Koen, AL, Izu, A, Fairlie, L, Cutland, CL, Baillie, V, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Aley, PK, Bhikha, S, Hermanus, T, Horne, E, Jose, A, Kgagudi, P, Lambe, T, Masenya, M, Masilela, M, Mkhize, N, Moultrie, A, Mukendi, CK, Moyo-Gwete, T, Nana, AJ, Nzimande, A, Patel, F, Rhead, S, Taoushanis, C, Thombrayil, A, van Eck, S, Voysey, M, Villafana, TL, Vekemans, J, Gilbert, SC, Pollard, AJ, Moore, PL, Kwatra, G

Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant by Madhi, SA, Baillie, V, Cutland, CL, Voysey, M, Koen, AL, Fairlie, L, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Kwatra, G, Ahmed, K, Aley, P, Bhikha, S, Bhiman, JN, Bhorat, AE, du Plessis, J, Esmail, A, Groenewald, M, Horne, E, Hwa, S-H, Jose, A, Lambe, T, Laubscher, M, Malahleha, M, Masenya, M, Masilela, M, McKenzie, S, Molapo, K, Moultrie, A, Oelofse, S, Patel, F, Pillay, S, Rhead, S, Rodel, H, Rossouw, L, Taoushanis, C, Tegally, H, Thombrayil, A, van Eck, S, Wibmer, CK, Durham, NM, Kelly, EJ, Villafana, TL, Gilbert, S, Pollard, AJ, de Oliveira, T, Moore, PL, Sigal, A, Izu, A